HomeCYAD • EBR
add
Celyad Oncology SA
Previous close
€0.45
Day range
€0.43 - €0.47
Year range
€0.21 - €1.22
Market cap
18.16M EUR
Avg Volume
29.88K
P/E ratio
-
Dividend yield
-
Primary exchange
EBR
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 7.00K | -68.18% |
Operating expense | 1.54M | -35.85% |
Net income | -1.52M | 18.61% |
Net profit margin | -21.74K | -155.80% |
Earnings per share | — | — |
EBITDA | -1.43M | 35.38% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.23M | 25.18% |
Total assets | 12.85M | 5.49% |
Total liabilities | 9.58M | -14.14% |
Total equity | 3.26M | — |
Shares outstanding | 41.43M | — |
Price to book | 5.62 | — |
Return on assets | -30.01% | — |
Return on capital | -90.62% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -1.52M | 18.61% |
Cash from operations | -1.42M | 66.02% |
Cash from investing | -59.00K | -112.23% |
Cash from financing | 1.09M | 2,232.35% |
Net change in cash | -387.50K | 89.62% |
Free cash flow | -924.31K | 27.00% |
About
Founded
2004
Headquarters
Website
Employees
18
